CRISPR-Engineered CAR-T Cells Production | Protocol Preview

GM-CSF Knock-out in CAR-T Cells by CRISPR/Cas9 | Protocol PreviewПодробнее

Using CRISPR and non-viral DNA in T Cell EngineeringПодробнее

CAR T Cells Production for Adoptive Immunotherapy | Protocol PreviewПодробнее

Engineering Next Generation CAR T Cells with CRISPRПодробнее

Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy ResearchПодробнее

EMBL Course | Genome engineering: CRISPR/Cas in cells and miceПодробнее

CRISPR ExplainedПодробнее

CRISPR/Cas9-based genome editing for autologous CAR-T cell productionПодробнее

CAR T Cell Therapy Explained (Animation) | City of HopeПодробнее

CRISPR-Cas9 Genome Editing TechnologyПодробнее

Developing autologous T-cell therapies with CRISPR-Cas technologyПодробнее

CAR-T Cells: Engineered Cancer Killers, Mechanism of ActionПодробнее

Bridging Synthetic Immunology and Genome Editing to Advance CAR-T Cell TherapiesПодробнее

High-throughput CRISPR-Cas9 Genome Engineering in Primary T CellsПодробнее

Reprogramming T Cells with CRISPR | Alex MarsonПодробнее

CAR-T Cells: Engineered Cancer KillersПодробнее

Inside the Lab: CAR T Cell Therapy Explained | City of HopeПодробнее

Professor Waseem Qasim - TALEN, CRISPR and base edited CAR T-cells for ALLПодробнее

B cell lymphoma model for CD19 CAR T Cells evaluation | Protocol PreviewПодробнее